Azoles

Last updated: November 01, 2022

Azoles

Watch later

Watch later

Action potentials in myocytes
Action potentials in pacemaker cells
Excitability and refractory periods
Cardiac excitation-contraction coupling
Antidiuretic hormone
Calcitonin
Phosphate, calcium and magnesium homeostasis
Vitamin D
Blood components
Innate immune system
Complement system
Cytokines
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
B- and T-cell memory
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Bone remodeling and repair
Muscular system anatomy and physiology
Neuromuscular junction and motor unit
Slow twitch and fast twitch muscle fibers
Muscle spindles and golgi tendon organs
Muscle contraction
Sliding filament model of muscle contraction
Nervous system anatomy and physiology
Neuron action potential
Adrenergic receptors
Sympathetic nervous system
Parasympathetic nervous system
Cholinergic receptors
Body fluid compartments
Movement of water between body compartments
Hydration
Renin-angiotensin-aldosterone system
Sodium homeostasis
Potassium homeostasis
Osmoregulation
Necrosis and apoptosis
Hypoxia
Ischemia
Inflammation
Wound healing
Oncogenes and tumor suppressor genes
Hyperplasia and hypertrophy
Atrophy, aplasia, and hypoplasia
Metaplasia and dysplasia
Pharmacodynamics: Drug-receptor interactions
Enzyme function
Pharmacodynamics: Agonist, partial agonist and antagonist
Pharmacodynamics: Desensitization and tolerance
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug metabolism
Cholinomimetics: Direct agonists
Muscarinic antagonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Sympathomimetics: Direct agonists
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Anticoagulants: Heparin
Anticoagulants: Warfarin
Monoclonal antibodies
Glucocorticoids
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
Antimetabolites: Sulfonamides and trimethoprim
DNA synthesis inhibitors: Metronidazole
Mechanisms of antibiotic resistance
Protein synthesis inhibitors: Aminoglycosides
Miscellaneous cell wall synthesis inhibitors
Integrase and entry inhibitors
Protease inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Azoles
Miscellaneous antifungal medications
Echinocandins
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Parathyroid conditions and calcium imbalance: Clinical
Parathyroid disorders and calcium imbalance: Pathology review
DNA replication
Transcription of DNA
DNA mutations
Translation of mRNA
Proteins
Resting membrane potential
Demyelinating disorders: Pathology review
Blood groups and transfusions
Microcirculation and Starling forces
Bacterial structure and functions
Staphylococcus epidermidis
Staphylococcus aureus
Staphylococcus saprophyticus
Streptococcus pneumoniae
Clostridium perfringens
Clostridium botulinum (Botulism)
Clostridium tetani (Tetanus)
Clostridium difficile (Pseudomembranous colitis)
Escherichia coli
Salmonella (non-typhoidal)
Enterobacter
Shigella
Vibrio cholerae (Cholera)
Campylobacter jejuni
Mycoplasma pneumoniae
Viral structure and functions
Varicella zoster virus
Human herpesvirus 8 (Kaposi sarcoma)
Epstein-Barr virus (Infectious mononucleosis)
Herpes simplex virus
Human herpesvirus 6 (Roseola)
Adenovirus
Human papillomavirus
Rhinovirus
Influenza virus
Norovirus
Rotavirus
Vaccinations
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Introduction to the lymphatic system
Mendelian genetics and punnett squares
Inheritance patterns
Muscular dystrophies and mitochondrial myopathies: Pathology review
Autosomal trisomies: Pathology review
Miscellaneous genetic disorders: Pathology review
Independent assortment of genes and linkage
DNA structure
Nuclear structure
Amino acids and protein folding
Gene regulation
Lac operon
Karyotyping
Gel electrophoresis and genetic testing
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
DNA cloning
Down syndrome (Trisomy 21)
Huntington disease
Williams syndrome
Cystic fibrosis
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Deep vein thrombosis
Deep vein thrombosis and pulmonary embolism: Pathology review
Immunodeficiencies: Clinical
Selective immunoglobulin A deficiency
Isolated primary immunoglobulin M deficiency
Dermatomyositis
Crohn disease
Complement deficiency
Lupus nephritis
Thymus histology
Lymph node histology
Spleen histology
Respiratory alkalosis

Transcript

Watch video only

The “azole” antifungals are a family of medications used to treat mycoses, or fungal infections.

Mycoses can be superficial, like on the skin or hair, or develop into systemic infections in immunodeficient people.

Antifungals work either through fungistatic action, meaning that they inhibit fungal growth, or through fungicidal action, meaning they kill the fungi.

Azoles are divided into two major families of antifungals: imidazoles and triazoles.

Most fungal cells have a tough outer cell wall and an inner cell membrane.

The cell membrane is mostly made of phospholipids with some sterol or modified steroid molecules mixed in.

Humans have cholesterol, while fungi have ergosterol.

Both sterol molecules help keep the cell membrane stable at a wide range of temperatures.

Now, the precursor to both molecules is lanosterol.

Fungi have a cytochrome p450 enzyme called fourteen-alpha-demethylase in their mitochondria and endoplasmic reticulums, which converts lanosterol to ergosterol.

Without ergosterol, the structure of the cell membrane will be disrupted.

This will cause membrane-bound proteins, like ion channels, to stop working properly.

The membrane also becomes fragile, which eventually leads to inhibition of fungal growth.

The azole antifungals include imidazoles, like clotrimazole, isoconazole, miconazole, butoconazole, fenticonazole, and ketoconazole; as well as triazoles like fluconazole, itraconazole and voriconazole.

The only difference between the two groups is the imidazoles contain an imidazole ring, while triazoles contain triazole rings.

These medications work by inhibiting the fourteen-alpha-demethylase enzyme.

However, they also inhibit human cytochrome P450 enzymes to a lesser degree.

Because of this, the vast majority of azoles come in topical form, and they’re commonly used to treat superficial mycoses.

Azole creams are used for treating dermatophytosis, or ringworm, which is a red, itchy, scaly, circular rash, on the feet, groin, or armpit area, caused by Trichophyton fungus.

These fungi are also responsible for the more common “athlete’s foot” or “jock itch”.

Additionally, azoles can be used to treat tinea versicolor, caused by Malassezia globosa.

This disease is characterized by hypopigmentation or hyperpigmentation in patches of skin.

Last but not least, topical azoles are also used to treat yeast infections, such as oral or vaginal candidiasis caused by Candida species.

Topical use of azole antifungals is generally considered to be safe, since absorption through the skin is minimal, and the most common side effect is skin irritation.

Key Takeaways

Azoles are synthetic antifungals with broad spectrum activity against various fungal infections. Azoles bind to the ergosterol molecule in the fungal cell membrane and cause holes to form, which damages the cell membrane and eventually kills the fungus. Examples of azoles include drugs like clotrimazole, fluconazole, and itraconazole. Some of the side effects of azoles include nausea and vomiting, gynecomastia, and hepatotoxicity.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Therapeutic tools for oral candidiasis: Current and new antifungal drugs" Medicina Oral Patología Oral y Cirugia Bucal (2019)
  5. "Adverse interactions between antifungal azoles and vincristine: review and analysis of cases" Mycoses (2011)